Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): A phase II multicenter exploratory study – Final data of patients who underwent surgical assessment - Provencio, M; Nadal, E; Insa, A (Poster Abstract Congress of the American Society of Clinical Oncology Journal (ASCO), 2019)
37(15_suppl): Poster 8509